Vision TeKardio 2.0 2017

Hindricks, G., M. Taborsky, M. Glikson, et al. (2014) Implant-based multiparameter telemonitoring of pati- ents with heart failure (IN-TIME): a randomised controlled trial. The Lancet, 384, 583 – 590. Hindricks, G. et al. (2017), Daily remote monitoring of implantable cardioverter-de- fibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST). Eur Heart J DOI: https://doi.org/10.1093/eurheartj/ ehx015 Kirchhof, P., S. Benussi, D. Kotecha, et al. (2016) 2016 ESC Guidelines for the management of atrial fibril- lation developed in collaboration with EACTS. European Heart Journal, 37, 2893 – 2962. Koplan, B. A., A. J. Kaplan, S. Weiner, et al. (2009) Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing neces- sary? J Am Coll Cardiol, 53, 355 – 60. Krämer, L. I., U. Wiegand, C. Stellbrink, et al. (2007) Curriculum“Praxis der Herzschrittmachertherapie“. Kar- diologe, 3, 177 – 186. Lazarus, A. (2007) Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resyn- chronization therapy systems: analysis of a worldwide da- tabase. Pacing Clin Electrophysiol, 30 Suppl 1, S 2 – 12. Lemke, B., B. Nowak, D. Pfeiffer (2005): Kurzfassung der Leitlinien „Leitlinien zur Herzschrittma- chertherapie“. Zeitschrift für Kardiologie, Band 94, Heft 10, 704 – 720. Lewalter, T. & Jilek, C. Herzschr Elektrophys (2016) 27: 337 Mabo, P., P. Defaye, N. Sadoul, et al. (2012) Remote follow up of patients implanted with an ICD_ The prospective randomized EVATEL study (abstr.). Heart Rhythm, 9, 226 – 267. Moss, A. J., W. Zareba, W. J. Hall, et al. (2002) Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction. New England Journal of Medicine, 346, 877 – 883. Mueller, A., K. Rybak, T. Klingenheben, et al. (2013) Empfehlungen zum Telemonitoring bei Patienten mit im- plantierten Herzschrittmachern, Defibrillatoren und kar- dialen Resynchronisationssystemen. Kardiologe, 7, 181 – 193. Nichols, M., N. Townsend, R. Luengo-Fernandez, et al. (2012) European Cardiovascular Disease Statistics 2012. ed. S. Logstrup. Brussels: European Heart Network. Nöthen, M. & K. Böhm. (2009) Krankheitskosten. In Gesundheitsberichterstattung des Bundes. Berlin: Robert Koch-Institut, Statistisches Bundesamt. o.V. (2014) Gesundheit – Todesfälle in Deutschland 2013. In Fachserie 12 Reihe 4, ed. S. B. (Destatis). Wiesbaden. Parthiban, N., A. Esterman, R. Mahajan, et al. (2015) Remote Monitoring of Implantable Cardioverter-Defibril- lators: A Systematic Review and Meta-Analysis of Clinical Outcomes. J Am Coll Cardiol, 65, 2591 – 600. Pfaff, H., H. Abholz, G. Glaeske, et al. (2011) Versorgungsforschung: unverzichtbar bei Allokationsent- scheidungen – eine Stellungnahme (Health services rese- arch: essential for allocation decisions – joint statement). Dtsch med Wochenschr, 136, 2496 – 2500. Ponikowski, P., A. Voors, S. D. Anker, et al. (2016a) Pocket Guidelines Herzinsuffizienz. Grünwald: Deutsche Gesellschaft für Kardiologie – Herz- und Kerislauffor- schung e.V. Ponikowski, P., A. A. Voors, S. D. Anker, et al. (2016b) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureThe Task Force for the diag- nosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 37, 2129 – 2200. Ricci, R. P. (2013) Disease management: atrial fibrillation and home moni- toring. Europace, 15 Suppl 1, i35 – i39. Rieder, A. & B. Lohff (2008) Geschlechtsspezifische Aspekte für die klinische Praxis. Wien: Springer. Rifkin, J. (2014) The Zero Cost Society: The Internet of Things, the Collabo- rative Commons, and the Eclipse of Capitalism. Macmillan USA. Roger, V. L. (2013) Epidemiology of Heart Failure. Circulation research, 113, 646 – 659. Rybak, K. (2016) Telemonitoring in der Devicetherapie: gelebte Wirklich- keit? (Telemonitoring in Device Therapy: a Living Reality?). Aktuel Kardiol, 5, 101 – 111. Sanna, T., H.-C. Diener, R. S. Passman, et al. (2014) Cryptogenic Stroke and Underlying Atrial Fibrillation. New England Journal of Medicine, 370, 2478 – 2486. Saxon, L. A., D. L. Hayes, F. R. Gilliam, et al. (2010) Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survi- val study. Circulation, 122, 2359 – 67. 80